Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5916808 | 0.95 | ACHE (0.46) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7572210 | 0.93 | ACHE (0.46) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5916593 | 0.93 | ACHE (0.46) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5916503 | 0.89 | KMT2A (0.41) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5916701 | 0.87 | EPHX1 (0.53) | ACHEEPHX1 | |
| SCHEMBL13978964 | 0.87 | ACHE (0.69) | ACHEEPHX1 | |
| SCHEMBL30358659 | 0.86 | ACHE (0.47) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL10018607 | 0.85 | ACHE (0.41) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8183970 | 0.84 | ALOX15 (0.41) | ACHE | |
| SCHEMBL2616704 | 0.84 | ACHE (0.51) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130079449-A1 | Polymer Composition and Method | SOLVAY SA (BE) | 2013-03-28 | — | — | US | claimed |
| WO-2013043321-A1 | POLYMER COMPOSITION AND METHOD | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-03-28 | — | — | WO | claimed |
| EP-3221324-B1 | PRODUCTION OF ISOCYANATE FUNCTIONAL ORGANOSILANES | WACKER CHEMIE AG (DE) | 2019-05-01 | — | — | EP | disclosed |
| US-10155779-B2 | Production of isocyanate functional organosilanes | WACKER CHEMIE AG (DE) | 2018-12-18 | — | — | US | disclosed |
| US-9914744-B2 | Method for producing carbamatoorganosilanes | WACKER CHEMIE AG (DE) | 2018-03-13 | — | — | US | disclosed |
| US-20170320896-A1 | PRODUCTION OF ISOCYANATE FUNCTIONAL ORGANOSILANES | WACKER CHEMIE AG (DE) | 2017-11-09 | — | — | US | disclosed |
| EP-3221324-A1 | PRODUCTION OF ISOCYANATE FUNCTIONAL ORGANOSILANES | Wacker Chemie AG (DE) | 2017-09-27 | — | — | EP | disclosed |
| EP-3046925-B1 | METHOD FOR PRODUCING CARBAMATOORGANOSILANES | WACKER CHEMIE AG (DE) | 2017-05-31 | — | — | EP | disclosed |
| EP-3046925-A1 | METHOD FOR PRODUCING CARBAMATOORGANOSILANES | Wacker Chemie AG (DE) | 2016-07-27 | — | — | EP | disclosed |
| US-20160200745-A1 | METHOD FOR PRODUCING CARBAMATOORGANOSILANES | WACKER CHEMIE AG (DE) | 2016-07-14 | — | — | US | disclosed |
| WO-2016078891-A1 | PRODUCTION OF ISOCYANATE FUNCTIONAL ORGANOSILANES | WACKER CHEMIE AG (DE) | 2016-05-26 | — | — | WO | disclosed |
| WO-2015040070-A1 | METHOD FOR PRODUCING CARBAMATOORGANOSILANES | WACKER CHEMIE AG (DE) | 2015-03-26 | — | — | WO | disclosed |
| US-20130079449-A1 | Polymer Composition and Method | SOLVAY SA (BE) | 2013-03-28 | — | — | US | disclosed |
| US-20060247407-A1 | Polymers with urea groups and silyl groups and production and use thereof | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) | 2006-11-02 | — | — | US | disclosed |
| US-7057001-B2 | Polymers with urea groups and silyl groups and production and use thereof | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2006-06-06 | — | — | US | disclosed |
| US-20050260401-A1 | Polymers with urea groups and silyl groups and production and use thereof | HENKEL AG & CO. KGAA (DE) | 2005-11-24 | — | — | US | disclosed |
| EP-1328586-A1 | POLYMERS WITH UREA GROUPS AND SILYL GROUPS AND PRODUCTION AND USE THEREOF | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-07-23 | — | — | EP | disclosed |
| WO-2002050020-A1 | METHOD FOR PRODUCING ISOCYANATES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-06-27 | — | — | WO | disclosed |
| WO-2002034838-A1 | POLYMERS WITH UREA GROUPS AND SILYL GROUPS AND PRODUCTION AND USE THEREOF | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160200745-A1 | METHOD FOR PRODUCING CARBAMATOORGANOSILANES | RCC2, DDT, NPEPPS | ACHE 273/4885HDAC3 3381/4885HDAC4 3878/4885 |
| US-10155779-B2 | Production of isocyanate functional organosilanes | PKD1, PCK1, PRKCA | ACHE 2078/4885HDAC3 1253/4885HDAC4 917/4885 |
| US-20170320896-A1 | PRODUCTION OF ISOCYANATE FUNCTIONAL ORGANOSILANES | PKD1, PCK1, PRKCA | ACHE 2078/4885HDAC3 1253/4885HDAC4 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.